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ABSTRACT
Mammalian, or mechanistic, target of rapamycin complex 2
(mTORC2) regulates a variety of vital cellular processes, and its
aberrant functioning is often associated with various diseases. Rictor
is a peculiar and distinguishingmTORC2 component playing a pivotal
role in controlling its assembly and activity. Among extant organisms,
Rictor is conserved from unicellular eukaryotes to metazoans. We
replaced two distinct, but conserved, glycine residues in both the
Dictyostelium piaA gene and its human ortholog, RICTOR. The
two conserved residues are spaced ∼50 amino acids apart, and
both are embedded within a conserved region falling in between
the Ras-GEFN2 and Rictor_V domains. The effects of point
mutations on the mTORC2 activity and integrity were assessed by
biochemical and functional assays. In both cases, these equivalent
point mutations in the mammalian RICTOR and Dictyostelium piaA
gene impaired mTORC2 activity and integrity. Our data indicate that
the two glycine residues are essential for the maintenance of
mTORC2 activity and integrity in organisms that appear to be
distantly related, suggesting that they have a evolutionarily conserved
role in the assembly and proper mTORC2 functioning.
KEY WORDS: Mammalian target of rapamycin, mTOR, AKT, PKB,
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INTRODUCTION
Mammalian, or mechanistic, target of rapamycin (mTOR) is a
serine/threonine kinase that belongs to the phosphatidylinositol
3-kinase-related kinase (PIKK) family. mTOR forms two
functionally distinct multi-protein complexes, namely mTOR
complex 1 (mTORC1) and mTOR complex 2 (mTORC2), which
differ in the regulatory subunits with which they associate (Zoncu
et al., 2011). For instance, regulatory associated protein of TOR
(Raptor) and proline-rich Akt substrate of 40-kDa (PRAS40) (also
known as RPTOR and AKT1S1, respectively, in mammals)
are mTORC1-specific constituents, whereas rapamycin-insensitive
companion of TOR (Rictor), Stress-activated map kinase-
interacting protein 1 (Sin1; also known as MAPKAP1) and
protein observed with Rictor 1 and 2 (Protor1/2; also known as
PRR5 and PRR5L, respectively), are specific for mTORC2. Other
proteins, like the TOR kinase itself, LST8 (also known as GβL and
MLST8) and DEP domain-containing TOR-interacting protein
(Deptor) are shared instead between mTORC1 and mTORC2.
With few notable exceptions, restricted to plants and some
Alveolata species, both TOR complexes are conserved among
extant organisms ranging from unicellular eukaryotes to animals
(Tatebe and Shiozaki, 2017). Both mTOR complexes (mTORCs)
function as multimers by sensing environmental cues and/or stress
conditions, thus ensuring a correct integration of the intracellular
and extracellular signals to promote cell growth, survival,
metabolism and motility (Sarbassov et al., 2005). Dysregulation
of mTOR signaling is observed in virtually all solid tumours and
hematologic malignancies, as well as in several neurodegenerative
and metabolic disorders (Dinner and Platanias, 2016; Lan et al.,
2017; Linke et al., 2017; Pópulo et al., 2012). While mTORC1 acts
predominantly on eukaryotic translation initiation factor 4E-binding
protein (14E-BP1) and p70/S6 kinase (p70/S6K) substrates,
mTORC2 phosphorylates AGC kinases such as AKT1 (also
known as protein kinase B, PKB; hereafter denoted AKT), serum
and glucocorticoid-activated kinase (SGK) and protein kinase C
(PKC) family members, thereby regulating their activation and/or
protein stability (Guertin et al., 2006). Currently available mTOR
inhibitors show promiscuous activity towards mTORC1 and
mTORC2, although rapamycin derivatives (Rapalogs) are rather
selective for mTORC1 during a short incubation (Kim et al., 2002).
The availability of small molecules capable of selective mTORC2
inhibition still remains an unmet need.
Essential for the design of specific mTORC2 inhibitors is the
detailed resolution of its 3D structure, as well as the elucidation of
the molecular mechanisms underlying both its proper regulation as
well its malfunctioning, which presently are still poorly understood.
Hitherto, the use of simple and genetically amenable model
organisms has been extremely beneficial for the investigation
of mTORC2 regulation. Dictyostelium discoideum is a social
amoeba that has long been used as a model system for studying
fundamental processes in cell and development biology (Bozzaro,
2013). Dictyostelium cells grow and divide mitotically but, upon
starvation, undergo a developmental program in which cells form
multicellular aggregates through chemotaxis, and eventually
fruiting bodies (Bozzaro, 2013). Unlike yeast, but similar to
what is found in animals, the Dictyostelium discoideum genome
encodes for a single TOR kinase, and mTORC2 is a key player
in many cellular processes. Single and multiple mutants in
the diverse mTORC2 components have been generated and
phenotypically characterized (Lee et al., 2005). As in other
organisms, targeted gene disruption of the Dictyostelium rictor
ortholog ( piaA) gene (Chen et al., 1997), henceforth referred to as
pia, led to severe developmental defects, mostly due to the
inability to activate downstream G-protein coupled receptor
(GPCR) signaling pathways, such as those mediated by adenylyl
cyclase A (ACA) and AKT (Kamimura et al., 2010). AmongReceived 15 July 2019; Accepted 15 October 2019
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Dictyostelium mTORC2 mutants, we isolated and characterized a
temperature-sensitive aggregation-deficient strain, named HSB1
(Bozzaro et al., 1987). HSB1 harbors a point mutation at codon
917 in the pia gene, resulting in the amino acid change G917D
(PiaG917D). At the non-permissive temperature, HSB1 cells
phenocopied pia-null cells (Pergolizzi et al., 2002). Besides the
Pia mutation affecting the mTORC2 activity, a missense mutation
(G1120E) of the C. elegans rictor gene (rict-1) has been isolated
and characterized. The corresponding mutation in mammals
(RictorG934E) was shown to prevent Rictor binding to Sin1 and
consequently the assembly of a functional mTORC2 (Aimbetov
et al., 2012).
Although Rictor family members do not possess clearly
identifiable structural protein domains or motifs, they share
regions of different length that are classified by PFAM and
SMART prediction software as Rictor_N, Rictor_M, Ras-GEFN2,
Rictor_V and Rictor Phospho (Sarbassov et al., 2004). The
structural and functional properties of these conserved regions is
still unknown.
In the present study, we carried out a comparative analysis of the
biochemical and cellular phenotypes of two distinct Pia and Rictor
mutants (Jones et al., 2009; Pergolizzi et al., 2002; Soukas et al.,
2009), both altered in two conserved glycine residues, in cells of the
social amoeba D. discoideum and Homo sapiens. We show that,
despite the evolutionary distance between these organisms, both
mutations cause similar biochemical and cellular effects.
RESULTS
Architectural domain evolution of Rictor proteins and
localization of functional glycine residues
Rictor is the largest mTORC2 protein subunit, and performs key
scaffolding function that are likely analogous to that of Raptor
in stabilizing the dimerization of mTORC1 (Sarbassov et al., 2004).
A detailed phylogenetic analysis revealed that, although Rictor
members are present in many phyla, their architectural organization
is significantly different among various species (Fig. S1).
Evolutionary analysis, based on the presence or absence of
different motifs as predicted by PFAM and SMART algorithms,
highlighted that even among the same clade, Rictor proteins showed
significant architectural variance. Indeed, among animals, when
comparing Chordata with Platyhelminthes and with Echinodermata,
we noticed that Rictor family members were poorly structurally
characterized. By contrast some lower eukaryotes (e.g. yeast
and amoebas) displayed a Rictor architecture closer to that of
Chordata than to other animal species (e.g. Echinodermata and
Platyhelminthes).
The detailed examination of the single point mutations that are so
far known to impair mTORC2 activity (PiaG917D and H. sapiens
RictorG934E), revealed that both of these glycine residues are
embedded within a linker peptide spanning from the end of the
Ras-GEFN2 until to the beginning of the Rictor_V domain, and in
both cases a non-polar amino acid is replaced by a negatively polar
charged residue. Remarkably, this region is predicted to be either
disordered or show low complexity in a number of Rictor proteins. It is
noteworthy that the mutated amino acid residues in theD. discoideum
PiaG917D, C. elegans RictorG1068E (formerly annotated as
RictorG1120E; Jones et al., 2009) and H. sapiens RictorG934E are
rather well conserved among different phyla and are located within the
second and the third repeated block of∼30 amino acids, that represent
a shared feature of Rictor proteins (Sarbassov et al., 2004) (Fig. 1A).
Interestingly, within the region spanning between the Ras-
GEFN2 and Rictor_V domains there are several conserved amino
acids showing a very high level of identity that can peak as high as
∼70% (e.g. glycine residue corresponding to the position 892 in
human Rictor) (Fig. 1B,C).
Although Rictor is an essential mTORC2 component, these
analyses suggest that the global domain architecture differs
significantly among various members. Therefore, establishing an
accurate structure-to-function relationship appears rather
challenging. By contrast, investigation of allelic variants affecting
mTORC2 activity might represent a more-powerful tool to identify
region(s) needed for mTORC2 integrity and function.
Dictyostelium PiaG963E does not rescue the HSB1 phenotype
and impairs the development of wild-type cells in a similar
manner to PiaG917D
The Dictyostelium temperature-sensitive strain HSB1, isolated as
aggregation-deficient mutant, harbors a point mutation in the pia
gene resulting in a single amino acid replacement at codon 917
(G917D) in the Pia protein. This mutation is responsible for the
aggregation-deficient phenotype, resulting from the inability to
activate ACA and thus to produce cyclic AMP (Pergolizzi et al.,
2002). Cyclic AMP is essential in Dictyostelium development,
because it acts as chemoattractant, hormone-like signal and
intracellular second messenger, hence regulating both chemotaxis
and the expression of genes required for aggregation and post-
aggregative development (Du et al., 2015; Loomis, 2014; Pergolizzi
et al., 2017a, 2002).
When reproducing the H. sapiens mutation (RictorG934E) in
Dictyostelium cells (PiaG963E), we observed that this mutation failed
to rescue the HSB1 aggregation-deficient phenotype (Fig. 2A).
Consistent with this, when expressed in AX2 cells, PiaG963E resulted
in delayed aggregation and fruiting body formation, as occurred
with PiaG917D (Pergolizzi et al., 2002) (Fig. 2B). However, the
PiaG963E protein was always found to be expressed at a lower level
than the wild-type (wt) or G917 proteins, probably as result of a
reduced protein stability, as was previously described for the
corresponding RictorG934E human mutation (Aimbetov et al., 2012).
Because this decreased protein stability is likely an intrinsic feature
of both the Dictyostelium and the corresponding human mutation,
we cannot formally rule out that the severe aggregation phenotype
seen with this mutant may depend in part on its reduced protein
level, besides an impaired TORC2 signaling activity. Considering
that in parental AX2 cells the wt Pia is normally expressed, the
aggregation and development delay observed when the mutated
forms are overexpressed could be the result of competition for
binding partners between the endogenous wt and the overexpressed
mutated Pia proteins (Pergolizzi et al., 2002).
A high-resolution version of the 3D Rictor structure is presently
missing, but these results indicate that the Pia mutant proteins
impair mTORC2 activity, suggesting a key functional role for both
of the conserved glycine residues located between the Ras-GEFN2
and Rictor_V domains.
Both Pia G917 and G963 are needed to preserve
Dictyostelium mTORC2 integrity
We have previously shown that HSB1 cells fail to activate mTORC2
by assessing the phosphorylation status of the hydrophobic motif
(HM) and activation loop (AL) of PKBA and PKBR1 as well as
their phosphorylated substrates by means of phospho-specific
antibodies (Pergolizzi et al., 2017b). Nevertheless, the question of
whether the mutated PiaG917D controlled mTORC2 integrity, or
solely its kinase activity, remained unanswered. To address this
issue, we examined the Pia–LST8 interaction in HSB1 cells
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stably co-expressing Piawt, PiaG917D or PiaG963E, and LST8. The
interaction between LST8 and mutated Pia proteins was severely
impaired when compared to Piawt (Fig. 3). This means that like
Dictyostelium Pia G917, Pia G963 is also an additional residue
required for the proper assembly of TORC2, in agreement with the
previously reported observations in mammalian cells (Aimbetov
et al., 2012).
Considering the high degree of conservation in the connecting
Ras-GEFN2-to-Rictor_V peptide among different Rictor family
members (Fig. 1) and the biological/biochemical effects caused by
both mutations on mTORC2 integrity, we surmise that both of these
two glycine residues may be essential for the proper integrity and/or
signaling activity of Dictyostelium TORC2.
Mammalian Rictor G884 is required for mTORC2 full activity
and partially controls its integrity
Since when reproduced in Dictyostelium, the human RictorG934E
mutation affects TORC2 activity by interfering with the integrity of
the complex, as occurs in mammals, we also decided to investigate
the effects of the corresponding Dictyostelium mutation PiaG917D in
the context of the human Rictor protein (RictorG884D).
Hence, we took advantage of a recently developed Rictor-
knockout (KO) A375 melanoma cell line developed in our
laboratory via CRISPR/Cas9 technology. As shown in Fig. 4A,
these cells do not display any detectable Rictor expression
as compared to wt A375 cells. While in wt A375 cells,
phosphorylation of bona fide mTORC2 protein targets, such as
AKT (at S473) was increased upon serum stimulation, in the Rictor
KO counterparts its level was nearly abolished even in presence of
serum. Moreover in the knockout cells, phosphorylation of PKCα at
S657, another known mTORC2 target site, was drastically
diminished along with the total levels of AKT and PKCα
proteins, consistent with the notion that mTORC2 also regulates
the overall stability of these proteins. In contrast, phosphorylation of
the mTORC1 substrate 4EBP1 at T37 and T46 (T36/47) was similar
to that of wt cells. Altogether, these findings indicate that this A375
Fig. 1. Rictor protein architectural organization of the conserved regions and region encompassing the two conserved Gly residues. (A) Schematic
representation of the mammalian Rictor protein conserved regions. Highly conserved regions of Rictor protein are shown in colored boxes: Rictor_N (blue),
Rictor_M (purple), Ras-GEFN2 (yellow), Rictor_V (green) and Rictor_Phosho (red). (B) Multiple sequence alignment of the peptide region between Ras-GEFN2
and Rictor_V of different species: Homo sapiens (UniProt Q6R327); Dictyostelium discoideum (UniProt O77203); Nematostella vectensis (UniProt A7SRE9);
Amphimedon queenslandica (UniProt A0A1X7UI29); Daphnia pulex (UniProt E9HCD6); Drosophila melanogaster (UniProt X2JL73); Phytophthora sojae
(UniProt G4YPP8); Monosiga brevicollis (UniProt A9V5T2); Paramecium tetraurelia (UniProt A0EHS6); Fusarium pseudograminearum (UniProt K3VWR9);
Saccharomyces cerevisiae (UniProt P40061);Caenorhabditis elegans (UniProt G5EFN2); Fonticula alba (UniProt A0A058ZD18); Strongylocentrotus purpuratus
(UniProt W4Y7H9); and Schistosoma mansoni (UniProt G4VPY8). The Dictyostelium G917 site aligns with the human G884, whereas the human G934 aligns
with the Dictyostelium G963 residue. The red rectangles in the multiple sequence alignment indicate the conserved residues among different clades. Protein
sequences alignment was performed with MUSCLE (www.ebi.ac.uk/Tools/nsa/muscle/). (C) WebLogo depicting the multiple sequence alignment of the peptide
sequence spanning between Ras-GEFN2 and Rictor_V of the different Rictor proteins. The logo consists of stacks of letters with one stack for each position in
the sequence. The overall height of the stacks indicates the relative frequency of each amino acid at that position. The logo was generated by using WebLogo
(http://weblogo.berkeley.edu/logo.cgi), a web-based application designed to generate sequence logos.
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Rictor KO cell line faithfully recapitulates features typical of
selective mTORC2 disruption in different cellular models (Guertin
et al., 2006; Tassone et al., 2017).
It has been previously reported that the low proliferation rate
observed in mammalian cells expressing the mutated RictorG934E is
due to inactive mTORC2 because of its inability to assemble
a mature complex (Aimbetov et al., 2012); therefore, we first
determined the effects of RictorG884D on cell proliferation. Rictor
KO cells were transiently transfected with either human Rictorwt or
with the mutated forms (RictorG884D or RictorG934E) and cell
proliferation was assessed using cells transfected with empty vector
as baseline control.
As shown in Fig. 4B, whereas expression of human Rictorwt led
to increased proliferation when compared to the control, neither of
the Rictor mutants had a significant effect on cell proliferation, as
revealed by an MTT assay.
We next examined the phosphorylation status of AKT S473, a
canonical mTORC2 substrate. The phosphorylation levels of AKT at
this site were lower in the Rictor KO A375 cells expressing
RictorG884D, RictorG934E or the empty vector, as compared to the
control cells expressing Rictorwt. Moreover, in cells expressing
mutant Rictor proteins, the phosphorylation profiles evidenced by an
antibody detecting the ‘canonical’ phosphorylated motif typical of
AKT- and other AGC-directed kinase substrates differed from those
of cells expressing wt Rictor, suggesting alterations in downstream
signaling (Fig. 5A). Cells expressing the mutant RictorG934E, as
detected by phosphorylation on S473, showed severe impairment in
kinase activity as previously reported (Aimbetov et al., 2012).
Since the PiaG917D mutation interferes with Dictyostelium
mTORC2 integrity, we decided to examine whether RictorG884D
could also interfere with the mammalian mTORC2 assembly by
assessing the RictorG884D–Sin1 and RictorG884D–LST8 interactions
in HEK 293T cells. Notably, in contrast to what occurs for Rictor
and Sin1, the interaction between Rictor and LST8 is not the result
of their direct association. Nevertheless, LST8 is an essential
mTORC2 component that is required to regulate its kinase activity
(Guertin et al., 2006; Lee et al., 2005).
The human RictorG884D mutation did not significantly interfere
with the interaction of the protein with Sin1 (∼30% less compared
to the wt form), which is different from what was been
previously observed with the RictorG934E, for which this
interaction is severely compromised (Fig. S2). Despite the fact
that RictorG934E protein levels in A375 cells were lower than those
of RictorG884D and Rictorwt, the effects on the mTORC2 signaling
outputs are likely more severe than those caused simply by its
reduced expression (∼80% inhibition of AKT phosphorylation
when normalized for Rictor revels; see Fig. 5B), although we cannot
formally rule out that also reduced protein dosage also contributes
to the inability of the mutant to support cellular growth, as shown
in Fig. 4B.
Fig. 2. Phenotype of HSB1 and AX2 Dictyostelium cells overexpressing wt pia and its mutated forms. HSB1 (A) and AX2 (B) cells were transfected
with piawt (pia/rictorwt), piaG917D (pia/rictorG917D) or piaG963E (pia/rictorG963E) genes (tagged with GFP). A 0.03 ml drop, at a concentration of 107/ml of the
selected clones, was plated on non-nutrient agar and development followed for 24 h. Experiments were carried-out at a temperature of 23°C. AX2::Pia/
RictorG917D and AX2::Pia/RictorG963E display a delay in the onset of aggregation and development. Several single cells are visible after 24 h of development.
HSB1::Pia/RictorG917D and HSB1:: Pia/RictorG963E fail to aggregate in contrast to HSB1::Pia/Rictorwt where fruiting bodies are detectable. Photographs were
taken at the indicated times. The immunoblots (IB) beside each set revealed the relative amount of the Pia protein expressed for each strain. Scale bar: 0.5 mm.
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By contrast, the RictorG884D–LST8 interaction is impaired to a
higher extent than the RictorG884D–Sin1 interaction (Fig. 5B). In
summary, these results indicate that the Dictyostelium mutation,
when reproduced in mammalian cells, not only impairs mTORC2
kinase activity but also partially interferes with the complex
integrity by reducing the incorporation of LST8 within TORC2.
DISCUSSION
Since the identification of mTORC2 as the main kinase responsible
for phosphorylation of the AKT S473, necessary for its maximal
activation, there has been an increasing body of evidence indicating
that mTORC2/AKT signaling dysregulations are associated with the
initiation and progression of several cancer types, as well as in the
Fig. 4. Biochemical and functional characterization of A375 Rictor KO cells. (A) Normal (wt) or Rictor knockout (KO) A375 cells were starved for 24 h
and then treated (+) or not (−) with FBS for 15 min. Afterwards, total cell lysates (TCLs) were analyzed by immunoblotting with the indicated antibodies detecting
phosphorylated and total mTORC2 and mTORC1 target proteins. (B) Rictor mutated forms affect cell proliferation. A proliferation assay was performed in
A375 cells knocked out for Rictor and transfected with the indicated Rictor mutants or empty vector. The assay was performed 48 h after transfection by seeding
10,000 cells per well in triplicates for each condition. The bar graph represents mean±s.d. values expressed as a percentage for at least three different
experiments relative to the proliferation obtained with Rictor KOA375 (set at 100%). Only transfection of wt humanRictor resulted in an increased proliferation rate
when compared to the control Rictor KO cells. **P<0.01 (Student’s t-test).
Fig. 3. Pia G917 and G963 are both necessary for the mTORC2 integrity. wt or mutated GFP-tagged pia plasmids [piawt (pia/rictorwt), piaG917D (pia/
rictorG917D) or piaG963E (pia/rictorG963E)] were co-expressed together with the LST8-T7 plasmid in AX2 cells. Cells starved for 4 h were then lysed at 4°C and
the soluble fraction isolated by centrifugation. For immunoprecipitation (IP), GFP-trap beads were added to the cleared cellular lysates followed by overnight
incubation with rotation at 4°C. Immunoprecipitates were analyzed for the indicated proteins by immunoblotting. The mutated forms of Pia display a very low
binding to LST8 in comparisonwith thewt. The lower expression level detected in the total cell lysate (TCL) for Pia/RictorG963Ewhen compared to thewt formmight
be due to a weaker protein stability, as occurs for the mammalian counterpart RictorG934E (Aimbetov et al., 2012). The bands intensities, corresponding to LST8
protein, were quantified using ImageJ. For every experimental condition (Pia/Rictorwt against the two mutated Pia forms) the highest amount of LST8measured in
TCL samples was given the value of 1. Afterwards, the TCL LST8 ratio calculated between the Piawt and the mutated Pia forms was used to normalize the
corresponding LST8 co- immunoprecipitated bands. To optimize signals, shorter and longer exposures of a representative experiment are shown. The normalized
mean±s.d. of at least three different experiments are plotted in the bar graphs.
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pathogenesis of neurodegenerative and metabolic disorders (e.g.
diabetes) (Johnson et al., 2015; Pópulo et al., 2012). Therefore,
there is a growing interest in selectively targeting the mTORC2/
AKT signaling axis. Rictor, together with Sin1, is an essential
mTORC2 component critical for its assembly. Alterations of Rictor
itself have also been identified in several cancer types including
prostate cancer, lung squamous cell carcinoma, sarcoma and
stomach cancer (Cheng et al., 2015; Kim et al., 2017). However,
since its identification, the structural and functional properties of
the unique conserved regions of the Rictor protein have remained
rather elusive.
With the present comparative study, for the first time, we have
elucidated the functions of two Pia point mutations in regulating
mTORC2 activity and integrity in a robust evolutionary conserved
manner. The mutations we analyzed are localized both within
an ∼60-amino-acid long peptide that is embedded between the
conserved Ras-GEFN2 and Rictor_V regions. Remarkably, these
mutations affect residues that are conserved between the lower
eukaryote Dictyostelium and the human Rictor. Our results show
that, in Dictyostelium cells, the PiaG917D mutation impairs the
mTORC2 activity because it interferes with the integrity of the
complex. When we reproduced the same mutation in the human
Rictor (G884D), the resulting protein altered the mTORC2
kinase activity and integrity, although to a lesser extent than the
corresponding Dictyostelium mutation PiaG917D. The partial
inconsistency between Dictyostelium PiaG917D and mammalian
RictorG884D could be due to several reasons. The Dictyostelium
HSB1 strain, harboring the PiaG917D, has been isolated as
temperature-sensitive strain indicating that the effect caused by the
mutation might be by-passed by shifting the cells to a lower
temperature. Indeed, HSB1 cells fail to aggregate at 23°C, but
aggregate and develop normally at temperatures below 18°C
(Pergolizzi et al., 2002). In many Rictor proteins from different
species, the linker peptide connecting the Ras-GEFN2 and Rictor_V
is characterized by an apparently low complexity or disordered
structure that conceivably is more prone to conformational transitions
upon temperature or energy changes. Moreover, although both
mammals and Dictyostelium share the same mTORC2 components,
they slightly differ in their structural composition. Several Rictor
proteins from different organisms, as well as the Dictyostelium Pia,
structurally diverge from that of Chordata due to their smaller size
and because they lack the so-called Rictor-Phospho region.
Currently, it is plausible to hypothesize that the weaker
RictorG884D–LST8 interaction, observed in human cells, is
responsible for the impaired kinase activity, given that LST8 is
crucial for the enzymatic regulation of mTORC2 (Guertin et al.,
2006). The Dictyostelium Sin1 ortholog (Rip3) does not possess a
PH domain, leaving unanswered the question of how Dictyostelium
mTORC2 is recruited to the plasma membrane. In addition,
mTORC2 components might act in a TOR-independent way (Gao
et al., 2010; Hagan et al., 2008; McDonald et al., 2008; Zhang et al.,
2010). Consistent with this, in Dictyostelium the Rip3-null and
Pia-null phenotypes differ substantially, suggesting that the role
of these proteins is not strictly and exclusively restricted to
mTORC2 (Lee et al., 2005). Overall, these differences may
explain the slightly distinct biochemical behavior that we have
observed between Dictyostelium and mammalian cells.
The secondmutation analyzed inDictyostelium cells corresponded
to human RictorG934E, which was already known to interfere with the
human mTORC2 activity and integrity (Aimbetov et al., 2012). The
same mutation in Dictyostelium Pia did not rescue the aggregation-
deficient HSB1 phenotype and delayed aggregation in wt AX2 cells,
similar to what was seen for the endogenous G917Dmutation. These
data strongly indicate that mTORC2 remained inactive. Consistent
with this, the biochemical characterization confirmed that mTORC2
failed to assemble into a mature complex, as occurred for the
PiaG917D mutation, strengthening the hypothesis that in
Dictyostelium, similar to in mammalian cells, adenylyl cyclase
Fig. 5. Rictor mutations interfere with mTORC2
activity and integrity. (A) Rictor mutant forms
impair mTORC2 activity. Immunoblot (IB) analysis of
mTORC2 substrate phospho-AKT S473 (pAKT,
AKTS473-P) and AKT substrates (α-P-PKB
substrates) in A375 Rictor KO cells transfected with
Rictorwt or mutants. AKT phosphorylation is
significantly reduced in the Rictor KO A375 cells
expressing RictorG884D, RictorG934E or empty vector,
when compared to the control cells expressing thewt
form of Rictor. Values underneath the corresponding
lanes represent the normalized levels of p-AKT
adjusted for the corresponding Rictor protein levels.
The wt level was set at 1. The signal from empty
vector-transfected cells (background level) was
subtracted from other values. Data represent the
mean of two independent experiments. (B)
RictorG884D interferes with mTORC2 integrity.
Immunoprecipitation of Rictor in HEK 293T cells co-
transfected with either Rictorwt or RictorG884D
together with Sin1 or LST8. For immunoprecipitation
(IP) Myc-trap beads were used. After 1 h of
incubation, immunocomplexes were washed and
subsequently analyzed by western blotting.
Quantification of Sin1 and LST8 immunoprecipitated
with Rictor were normalized to the Sin1 and LST8
values obtained with the Rictorwt form. Bar graphs
represent the mean±s.d. of three independent
experiments. *P<0.05 (Student’s t-test).
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activation requires mTORC2 (Liu et al., 2010). The effects of the
PiaG963E mutation are considerably detrimental despite the lower
protein amount when compared to the wt counterpart. Overall, these
data suggest that PiaG963E, when expressed in wt strain cells, avidly
competes with the endogenous wt protein, thus acting as dominant
negative. Additionally, these observations lead us to presume that, in
Pia, the replacement of a non-polar glycine residue with a negatively
charged one, such as glutamate (E) at codon 963, likely enhances the
protein instability. Given that a similar behavior has also been
observed for human Rictor, it is reasonable to assume that the glycine
residue is evolutionarily important from amoebas to human, because
it affects the protein stability. Further experiments will be required to
elucidate the reason(s) leading to weaker PiaG963E and RictorG934E
stability.
The finding that the functional characterization of these two
mutations in different cell types leads to similar results indicates that
these glycine residues play a crucial, and evolutionary conserved,
role either in regulating mTORC2 kinase activity or, to different
extent, integrity. Remarkably, none of these mutations is annotated
as a single nucleotide polymorphism (SNP) and both are predicted
to be hazardous/deleterious by PolyPhen-2 (Adzhubei et al., 2010)
and SIFT/PROVEAN (Kumar et al., 2009). A missense point
mutation affecting the human RICTOR gene at codon 855 (R855W),
closely located to the amino acids we analyzed, has been predicted
to be deleterious and associated with Tourette syndrome (Eriguchi
et al., 2017). These findings, together with our results, suggest that
the peptide spanning from Ras-GEFN2 to Rictor_V represents a
crucial regulator for mTORC2.
How these glycine residues are mechanistically essential for
regulating mTORC2 enzymatic activity and integrity still remains
elusive. The recently reported S. cerevisiae TORC2 structure reveals
a rhombohedral pseudo-two-fold symmetric shape with a
pronounced central cavity resembling that of mTORC1.
Nevertheless, the exact surfaces mediating the assembly, substrate
specificity and enzymatic activity, as well as the role of the
prominent central cavity, remain rather enigmatic and not entirely
identified (Karuppasamy et al., 2017). Intra- and inter-molecular
crosslinking data suggest that Avo3, the yeast ortholog of the
mammalian Rictor, wraps around TOR2 and that parts of AVO3 are
very close to the FKBP12 rapamycin-binding domain (FRB). The
AVO3 amino acid residues corresponding to those we have
investigated in the present study might be localized very near to
the FRB, thus likely assigning this region a crucial role in regulating
the kinase activity. A computational investigation, using combined
bioinformatic tools, has examined the sequence and structural
properties of the human Rictor protein, revealing that Rictor
possesses a HEAT and WD40 domain, further identifying a
ribosome-binding domain and two possible PH domains, one of
which splits (Zhou et al., 2015). Interestingly, the mutations we
have analyzed are localized around the predicted PH domains.
Based on the current and previous findings, we assume that whereas
the G934 is essential for the Rictor–Sin1 heterodimer formation,
the G884 residue is needed for the correct assembly of the LST8
into mTORC2. Although LST8 is not a unique mTORC2
component, it is essential for the kinase activity thus its partial
displacement leads to impaired enzymatic activity. Overall,
these data suggest that these residues are crucial for the regulation
of the TOR complex 2 by controlling the supramolecular protomer
assembly.
Despite the recent advances in exploring the 3D structure
of mTORC2, our understanding of its regulation and signaling
outputs is still rudimentary, thus the issue of whether potential
mTORC2-specific inhibitors will be clinically useful remains
hypothetical. Within this scenario, our present findings reveal that
mutations in two conserved glycine residues in Rictor, initially
found in mammals and Dictyostelium, exhibit common effects
when present in either organism, indicating that these residues play a
pivotal role in regulating mTORC2 activity and integrity.
Furthermore, we provided evidence that Dictyostelium might
represent a novel and useful model tool to improve our current
knowledge concerning mTORC2 enzymatic regulation. Gaining
molecular insights into mTORC2 assembly and regulation, by
making use of simple model organisms, would facilitate the rational
design of compounds that (i) prevent or disrupt mTORC2 assembly,
(ii) block access of substrates to the active site, (ii) prevent the
interaction of upstream activators, or (iv), in some cases, hyper-
activate mTORC2.
MATERIALS AND METHODS
Dictyostelium discoideum cell culture and development
Parental AX2 and mutant HSB1 strains were cultured axenically in AX2
medium (Ashworth and Watts, 1970) at 23°C under shaking at 150 rpm
as previously described (Pergolizzi et al., 2017b). For inducing
development, exponentially growing cells were washed twice in 0.017 M
Soerensen Na/K phosphate buffer, pH 6.1, resuspended at 107 cells per ml
and starved for the indicated time either plated on non-nutrient agar or
incubated under shaking at 150 rpm, as previously described (Pergolizzi
et al., 2017b).
Dictyostelium plasmids construction and generation of cell lines
co-expressing wt or mutated Pia with LST8
GFP–pia expression vectors were constructed as previously described
(Pergolizzi et al., 2002). The piaAwt gene was used as template to generate
the mutated piaG963E form using the QuikChange II site-directed
mutagenesis kit (Agilent Technologies, catalog # 200518) with specific
primers named FORWPiaG963E and REVPiaG963E (Table S1).
The G963E mutation was verified by DNA sequencing. The plasmids
obtained were used to transfect AX2 and HSB1 cells to generate stable cell
lines. Positive clones were selected for their resistance to G418 (20 µg/ml)
and visually screened by fluorescence microscopy (Peracino et al., 2006).
The wt or mutated GFP-tagged Rictor plasmids were co-electroporated
with the LST8 overexpressor plus T7-tag vector (plasmid #247, http://
dictybase.org) in AX2 cells. G418-resistant clones were isolated and
subjected to western blotting to identify those expressing both proteins.
Mammalian cell culture
A375 melanoma (ATCC CRL-1619) and human embryonic kidney 293T
(provided by Guido Serini, Dept. of Oncology, University of Torino, Italy)
cell lines were maintained in DMEM supplemented with 10% fetal bovine
serum (FBS), 500 U/ml penicillin and 0.5 mg/ml streptomycin as
previously described (Panuzzo et al., 2015). Cells were cultured at 37°C
in a humidified atmosphere flushed with 5% CO2.
CRISPR/Cas9-induced A375 Rictor KO melanoma cell lines were
generated as follows. First, two independent sgRNAs targeted to human
RICTOR exon 3 were selected using the UCSC Genome Browser
[target sequences: 5′-CCATCTGAATAACTTTACTA-3′ (Sg1) and 5′-
CCTTAGTAAAGTTATTCAGA-3′ (Sg2)]. Double-stranded DNA
oligonucleotides encoding for Sg1 and Sg2 were cloned into the BsbI site
of the pSpCas9 (BB)-2A-Puro (PX459) V2.0 plasmid (Addgene #62988;
Ran et al., 2013). Subconfluent A375 cells were transfected with 4 µg of
Sg1- or Sg2-carrying plasmid using Lipofectamine® 2000 in six-well plates.
After 24 h, cells were then selected with puromycin (2 µg/ml) for a further
48 h. After selection, individual colonies were isolated with cloning disks
and analyzed for Rictor protein expression and phosphorylation or
expression of bona fide mTORC2 target proteins. Rictor KO clones
generated with Sg1 were used in the present study.
When needed, serum stimulation was performed as follows: cells were
serum starved for 24 h and then stimulated for 15 min with 10% FBS.
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Homo sapiens plasmid construction and transient protein
expression
myc-RICTOR (plasmid #11367), HA-SIN1 (plasmid #12583) and HA-
LST8 (plasmid #1865) (Sarbassov et al., 2004) were purchased from
Addgene. The Rictor plasmids harboring G884E and G934E mutations,
were generated using the QuikChange II site-directed mutagenesis kit
(Agilent Technologies, catalog #200518). For the mutagenesis reaction, we
employed the Rictorwt plasmid as template and the primers
FORWRictorG934EH.s., REVRictorG8934EH.s., FORWRictorG884DH.s. and
REVRictorG884DH.s. (Table S1). For transient transfection, the plasmids
were transfected either in A375 or HEK 293T cells using Lipofectamine®
(Lipofectamine 2000, Thermo Fisher Scientific) according to the
manufacturer’s instruction.
Proliferation assay
Mammalian cell proliferation was assessed via an MTT assay (Sigma-
Aldrich) as described previously (Di Savino et al., 2015). Briefly, cells were
plated in 96-well plates by seeding 10,000 cells per well and grown for 48 h.
Afterwards, MTT was added and samples incubated at 37°C for
approximately a couple of hours and absorbance measured at OD 590 nm
using a plate reader. The obtained staining was proportional to the number of
proliferating cells. The data are expressed as a percentage with respect to the
not transfected cells, set to 100%, as the mean values±standard deviation
(s.d.) of at least three independent experiments. Each condition was
performed in a technical triplicate.
Cell lysis, immunoprecipitation and western blotting
Dictyostelium and mammalian total protein cell extraction was performed as
described previously (Aimbetov et al., 2012). Protein extracts were further
clarified by centrifugation at 12,000 g for 15 min at 4°C and subsequently
quantified with a Bradford protein assay (BioRad Laboratories, CA). For
immunoprecipitation, ∼1.5 mg of total protein extracts were processed with
Myc-TRAP or GFP-TRAP beads (Myc-TrapA and GFP-TrapA,
Chromotek, Germany).
Afterwards, samples were resolved by SDS-PAGE (8% gels) and
subsequently transferred onto PVDF membrane. Immunoblots were then
probed overnight at 4°C with specific antibodies in TBS (NaCl 150 mM,
Tris-HCl 20 mM pH7.4), 0.1% Tween, 1% BSA, and protein detection
performed by using peroxidase-conjugated secondary antibodies and
chemiluminescence reagent (Clarity Western ECL Substrate #170-5061,
Bio-Rad). Primary antibodies against the following were used: AKT
(#9272 Cell Signaling Technology, 1:1000); phospho-AKT S473 (sc-
7985-R Santa Cruz Biotechnology, 1:1000); phospho-Akt Substrate
(RXXS*/T*) (#9614 Cell Signaling Technology, 1:1000), phospho-PKCα
Ser-657 (#06-822, UpState, 1:1000), PKCα (sc-208 Santa Cruz
Biotechnology, 1:1000), Rictor (sc-271081, Santa Cruz Biotechnology,
1:250), T7 TAG (A190-217A Bethyl, 1:1000), GFP, from Dictyostelium
community (Westphal et al., 1997), Myc (#2276 Cell Signaling Technology,
1:1000), phospho-4E-BP1 Thr37/46 (#2855 Cell Signaling Technology,
1:1000), 4E-BP1 (#9452 Cell Signaling Technology, 1:1000) and tubulin
(#T5168, Sigma-Aldrich, 1:1000). Films were exposed for different time
periods to optimized signals.
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